RT-PCR test quantifying CP mRNA in blood can detect hepatocellular carcinoma early—especially in AFP-negative cases—offering ...

The FDA approved nivolumab and ipilimumab for unresectable or metastatic hepatocellular carcinoma ... diseases are most susceptible to the cancer. 2 Symptoms of the cancer can include a feeling ...

TWO toilet related symptoms could be the first signs of a hard-to-spot cancer that’s on the rise in the UK. Bile duct cancer ...

Research showed that nearly two-thirds of patients sustained clinically meaningful relief over 4 years after a 60-day PNS treatment for chronic low back pain.

There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

U.S. medical centers have appealed to the FDA for compassionate use approval of the adenosine receptor inhibitor namodenoson for pancreatic cancer, according to Can-Fite BioPharma. About 85% of ...

Y-90 radioembolization is primarily used for patients with inoperable liver cancer, including hepatocellular carcinoma ... treatments and can help manage symptoms, improve quality of life and ...

The technology aims to improve early detection of hepatocellular carcinoma ... cancer which turned out to be a Stage 2 liver cancer. I had no symptoms. I was referred immediately for expert ...

Replimune Group, Inc.'s RP1 + OPDIVO for advanced melanoma gains FDA Priority Review. PDUFA date: July 22, 2025. Read more on ...

The report includes clinical and nonclinical drug profiles, therapeutic assessments, and details on emerging drugs like Ricolinostat and CKD 506. Ideal for stakeholders in oncology and therapeutic R&D ...